Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Matin, Khalid	Virginia Commonwealth University United States	VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program	3UG1CA189869-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mcguire, Andrew	Fred Hutchinson Cancer Center United States	Rational Vaccine Design to prevent HIV-Associated Lymphoma	5R01CA285227-02
Mclouth, Laurie	University Of Kentucky United States	Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment	5R01CA283929-03	Brennan Streck, Ph.D., RN, M.P.H.
Md, Nicholas Dibella	Western States Cancer Research Ncorp United States	NCORP: Colorado Cancer Research Program	3UG1CA189805-11S1	Vanessa A. White, M.P.H.
Meghani, Salimah H.	University Of Pennsylvania United States	Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study	3R01CA270483-04S1	Gabriela Riscuta, M.D., CNS
Mehrara, Babak J	Sloan-Kettering Inst Can Research United States	Mechanisms of racial disparity in breast cancer-related lymphedema	5R01CA278599-03
Mehta, Anand S.	Medical University Of South Carolina United States	Glycan Biomarkers for Cholangiocarcinoma	1R01CA289381-01A1	Sidney Fu, M.D.
Melemedjian, Ohannes Kevork	University Of Maryland Baltimore United States	Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy	4R01CA249939-02	Rachel Altshuler, Ph.D.
Mello-Thoms, Claudia R	University Of Iowa United States	Satisfaction of Search in Breast Cancer Detection	5R01CA259048-05
Metzger, Gregory John	University Of Minnesota United States	Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI	4R01CA241159-05	Guillermo Marquez, Ph.D.
Milanovich, Samuel J.	Sanford Research/Usd United States	Sanford Community Cancer Program of the North Central Plains (NCORP)	3UG1CA189825-11S1	Vanessa A. White, M.P.H.
Milbury, Kathrin	University Of Tx Md Anderson Can Ctr United States	Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers	4R37CA231522-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Miyano, Masaru	Beckman Research Institute/City Of Hope United States	Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials	1R03CA300614-01	Sidney Fu, M.D.
Morilak, David A	University Of Texas Hlth Science Center United States	Therapy-induced cognitive impairment in a rat model of prostate cancer	5R01CA285183-03	John Clifford, Ph.D.
Morin, Olivier	University Of California, San Francisco United States	Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity	1R01CA292043-01A1	Marjorie Perloff, M.D.